(NYSE: STE) Steris's forecast annual revenue growth rate of 6.17% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Steris's revenue in 2024 is $5,133,661,000.On average, 3 Wall Street analysts forecast STE's revenue for 2025 to be $541,119,240,198, with the lowest STE revenue forecast at $540,155,458,769, and the highest STE revenue forecast at $541,603,152,556. On average, 3 Wall Street analysts forecast STE's revenue for 2026 to be $572,934,677,975, with the lowest STE revenue forecast at $571,651,674,148, and the highest STE revenue forecast at $575,085,509,139.
In 2027, STE is forecast to generate $606,278,478,034 in revenue, with the lowest revenue forecast at $602,542,382,725 and the highest revenue forecast at $610,014,573,343.